Drug May Work Against Advanced Thyroid Cancer
Sorafenib appeared to delay disease progression, shrink tumors in early studyContinue Reading
Sorafenib appeared to delay disease progression, shrink tumors in early studyContinue Reading
Women who got the drug plus standard chemo lived about 4 months longer on averageContinue Reading
Study found it prolonged remission after chemotherapy almost six months longer than a placeboContinue Reading
In preliminary trial, nivolumab shrank tumors in 30 percent of tough-to-treat patientsContinue Reading
10 years on the drug did increase side effects, but survival gains may be worth it, researchers sayContinue Reading
Tendency to overeat is nearly doubled for those victimized as kidsContinue Reading
So-called ‘study drugs’ don’t boost grades, and abusing them is dangerous, researchers warnContinue Reading
Tumor growth suppressed in lab tests; human trials still needed, study authors sayContinue Reading
But treatment advances have reduced overall deaths over past two decadesContinue Reading
Delicate balance exists between treating anemia, avoiding side effects from infusion of red blood cells, study saysContinue Reading
Majority would give a prescription to an advanced cancer patient in painContinue Reading
This cancer is leading cause of death from skin diseaseContinue Reading
Analysis shows no greater threat of addiction to alcohol, cocaine, marijuana, nicotine or other drugsContinue Reading
Memory chips help prevent release of unwanted productsContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.